The importance of active efflux systems in the quinolone resistance of clinical isolates of Salmonella spp
- 1 November 2004
- journal article
- Published by Elsevier in International Journal of Antimicrobial Agents
- Vol. 24 (5) , 428-432
- https://doi.org/10.1016/j.ijantimicag.2004.05.004
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- Effect of an efflux pump inhibitor on the MIC of nalidixic acid for Acinetobacter baumannii and Stenotrophomonas maltophilia clinical isolatesJournal of Antimicrobial Chemotherapy, 2002
- Fluoroquinolone resistance inSalmonellaserovars isolated from humans and food animalsFEMS Microbiology Reviews, 2002
- In vitro activity of clinafloxacin in comparison with other quinolones against Stenotrophomonas maltophilia clinical isolates in the presence and absence of reserpineDiagnostic Microbiology and Infectious Disease, 2002
- Association between cyclohexane resistance in Salmonella of different serovars and increased resistance to multiple antibiotics, disinfectants and dyesJournal of Medical Microbiology, 2001
- Natural antibiotic susceptibility of Salmonella enterica strainsInternational Journal of Antimicrobial Agents, 2000
- Efflux-Mediated Resistance to Fluoroquinolones in Gram-Negative BacteriaAntimicrobial Agents and Chemotherapy, 2000
- Ecological impact of antibiotic use in animals on different complex microflora: environmentInternational Journal of Antimicrobial Agents, 2000
- Antibiotic resistance monitoring: the Spanish programmeInternational Journal of Antimicrobial Agents, 2000
- Multidrug Efflux Pump AcrAB of Salmonella typhimurium Excretes Only Those β-Lactam Antibiotics Containing Lipophilic Side ChainsJournal of Bacteriology, 1998
- Multidrug efflux pumps of gram-negative bacteriaJournal of Bacteriology, 1996